|
|
| Product Name: | GSK J2 | | Synonyms: | SK-J2;GSK J2;GSK-J2;N-[2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine;CS-1294;β-Alanine, N-[2-(3-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-;3-((2-(pyridin-3-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoic acid;GSK-J-2,GSK J2,GSKJ2 | | CAS: | 1394854-52-4 | | MF: | C22H23N5O2 | | MW: | 389.45 | | EINECS: | | | Product Categories: | | | Mol File: | 1394854-52-4.mol |  |
| | GSK J2 Chemical Properties |
| Boiling point | 609.9±55.0 °C(Predicted) | | density | 1.292±0.06 g/cm3(Predicted) | | storage temp. | Desiccate at RT | | solubility | DMSO:40.47(Max Conc. mg/mL);103.91(Max Conc. mM) | | form | Powder | | pka | 4.22±0.10(Predicted) | | color | White to off-white |
| | GSK J2 Usage And Synthesis |
| Uses | GSK J2 is the inactive isomer of GSK J1(G797553), which is a selective and potent inhibitor of JMJDE and UTX demethylases. | | Definition | ChEBI: 3-[[2-(3-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid is an organonitrogen heterocyclic compound. | | storage | Desiccate at RT |
| | GSK J2 Preparation Products And Raw materials |
|